Evidence map›Paper›PMID 32154600›Full record

ArticleThe EMBO journal2020

Light-responsive microRNA miR-211 targets Ezrin to modulate lysosomal biogenesis and retinal cell clearance.

Federica Naso, Daniela Intartaglia, Danila Falanga, Chiara Soldati, Elena Polishchuk, Giuliana Giamundo, Paola Tiberi, Elena Marrocco, Paolo Scudieri, Chiara Di Malta and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Exploiting autophagy and related pathways: pioneering new horizons in cataract therapy.Apoptosis : an international journal on programmed cell death · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Lysosomes in retinal health and disease.Trends in neurosciences · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Federica Naso *Telethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Daniela Intartaglia *Telethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Danila FalangaTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Chiara SoldatiTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Elena PolishchukTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Giuliana GiamundoTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Paola TiberiTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Elena MarroccoTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Paolo ScudieriTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Chiara Di MaltaTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Ivana TrapaniTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Edoardo NuscoTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Francesco Giuseppe SaliernoTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Enrico Maria SuraceTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Luis Jv GaliettaTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Sandro BanfiTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.ORCID 0000-0002-6541-8833
Alberto AuricchioTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Andrea BallabioTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.ORCID 0000-0003-1381-4604
Diego Luis MedinaTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.
Ivan ConteTelethon Institute of Genetics and Medicine, Pozzuoli (Naples), Italy.ORCID 0000-0002-8968-9021
Telethon Institute Of Genetics And Medicine · ITBaylor College of Medicine · USUniversity of Campania "Luigi Vanvitelli" · IT

Funding

MODULATION OF CELLULAR CLEARANCE TO TREAT HUMAN DISEASER01NS078072 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI BALLABIO, ANDREA · 2012 to 2020
$3.1M
Associazione Italiana per la Ricerca sul Cancro 21052Associazione Italiana per la Ricerca sul Cancro 22103BrightFocus Foundation M2015317European Research Council (ERC) 311682European Research Council (ERC) 694282Fondazione Telethon (Telethon Foundation) TGM16CB6Fondazione Telethon (Telethon Foundation) TMICCBX16TTHuffington FoundationMinisterio dell'Istruzione, dell'Universita e della Ricerca RBAP11Z3YANINDS NIH HHS R01 NS078072
6 · The paper itself

Abstract

Vertebrate vision relies on the daily phagocytosis and lysosomal degradation of photoreceptor outer segments (POS) within the retinal pigment epithelium (RPE). However, how these events are controlled by light is largely unknown. Here, we show that the light-responsive miR-211 controls lysosomal biogenesis at the beginning of light-dark transitions in the RPE by targeting Ezrin, a cytoskeleton-associated protein essential for the regulation of calcium homeostasis. miR-211-mediated down-regulation of Ezrin leads to Ca

Indexed as

Gene Expression RegulationAnimalsAutophagyCalciumCytoskeletal ProteinsDown-RegulationEzrinLightLysosomesMiceMice, KnockoutMicroRNAsPhagocytosisPhagosomesRetinal Pigment EpitheliumCalciumCytoskeletal ProteinsEzrinMicroRNAsMirn211 microRNA, mouseautophagyEzrinmiR-211RPETFEB

Identifiers

PMID32154600
PMCPMC7156966
OpenAlexW3011571820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.